MIGDAL HA'EMEK, Israel, Aug. 31 -- Medical imaging developer Applied Spectral Imaging Ltd. has received $11 million from Tintanic Corp. B.V. (a holding company for TAT Capital Partners Ltd. and Private Equity Holding Inc. managed by Bank Von Tobel), New Medical Technologies and its current investors.
Along with the investment, Rolf Haegler, managing director of TAT, has been assigned to Applied Spectral Imaging's board of directors.
ASI's technology opens up new possibilities in medical imaging. We were particularly attracted to the broad range of possible applications that can benefit from their technology as well as their quality management team which has rapidly brought new applications to market in ophthalmology and pathology, said Haegler.
The investment will go towards the continued development and commercialization of products in ophthalmology, pathology and new non-invasive intraoperative neurosurgical navigation systems.